Document 1068
 DOCN  M9471068
 TI    Gynecologic oncology. 2nd ed.
 DT    9409
 AU    Anonymous; No affiliation given
 SO    Gynecologic Oncology. 2nd Ed. Coppleson M, ed. New York, Churchill
       Livingstone, 2 vol., 1525 p., 1992.. Unique Identifier : AIDSLINE
       ICDB/94696705
 AB    Rapid advances in both scientific and clinical aspects of the specialty
       in the 10 yr since the 1st edition of Gynecologic Oncology mandated the
       present 2nd edition which, because of this growth, contains an
       additional 12 chapters. The bulk of the book deals in detail with the
       gynecologic malignancies, presenting clinical features, staging,
       diagnosis, management, and prognosis. This comprehensive, encyclopedic
       account of the current state of the art includes the following: (1)
       fundamental principles (epidemiology, viruses in human tumors,
       carcinogenesis, immune system and gynecologic cancer, oncological
       endocrinology, selection of cytotoxic drugs, radiotherapy, statistics,
       clinical trials); (2) diagnostic aids (cytopathology, colposcopy,
       hysteroscopy, lymphography, arteriography, venography, MRI, CT,
       immunoscintigraphy, ultrasound, laparoscopy, needle biopsy, surgical
       staging, tumor markers); (3) malignancies (tumors of vulva and vagina,
       tumors of vagina and cervix and related abnormalities in young females
       exposed to DES, carcinoma of cervix, carcinoma of endometrium and its
       precursors, uterine sarcomas, tumors of fallopian tube and broad
       ligament, tumors of ovary, presacral tumors, trophoblastic tumors,
       miscellaneous malignant tumors of the female genital tract); (4)
       malignant tumors in pregnancy; (5) surgical techniques (CO2 laser,
       cryosurgery, electrocoagulation and conization of cervix, abdominal
       incisions and sutures, conservative and radical procedures); (6)
       management of complications of radical therapy (surgery and
       radiotherapy); (7) surgical reconstruction of the gynecologic oncology
       patient; and (8) after care (gynecologic pain, sexual morbidity
       following gynecologic cancer, psychological processes of recovery,
       palliative care for the patient with far advanced gynecologic cancer,
       attitudes to dying).
 DE    Antineoplastic Agents/THERAPEUTIC USE  Cervix Neoplasms/CHEMICALLY
       INDUCED/PATHOLOGY  Diethylstilbestrol  Female  *Genital Neoplasms,
       Female/DIAGNOSIS/MORTALITY/PATHOLOGY/THERAPY  Human  Prognosis
       Radiotherapy  Surgery, Operative  Vaginal Neoplasms/CHEMICALLY
       INDUCED/PATHOLOGY  MONOGRAPH

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).